DGX

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Jeremy GranthamGMO $369M1.9M shares AddQ1 2026 $54M $195.98 $193.99
Chris DavisDavis Selected Advisers $317M1.6M shares AddQ1 2026 $41M $195.98 $193.99

Congress Trades

Actor	Trade Size	Last Transaction	Amount Range	Price	Current Price
Carol Devine MillerRepublican $8.0k46.2 shares OtherMar 10, 2025 $1k-$15k $173.12 $193.99

Insider Trades

Actor	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Carter Robert BDirector --1.1k shares Grant / ExerciseMay 20, 2026 Disclosure amount unavailable1.1k shares -- $193.99
Carter Robert BDirector --1.1k shares Grant / ExerciseMay 20, 2026 Disclosure amount unavailable1.1k shares -- $193.99
Diaz LuisDirector --1.1k shares Grant / ExerciseMay 20, 2026 Disclosure amount unavailable1.1k shares -- $193.99
Diaz LuisDirector --1.1k shares Grant / ExerciseMay 20, 2026 Disclosure amount unavailable1.1k shares -- $193.99
Doi TraceyDirector --1.1k shares Grant / ExerciseMay 20, 2026 Disclosure amount unavailable1.1k shares -- $193.99
Doi TraceyDirector --1.1k shares Grant / ExerciseMay 20, 2026 Disclosure amount unavailable1.1k shares -- $193.99

News

zacks.com4 Outpatient Home Health Stocks Benefiting From Industry Trendszacks.comJun 9

investorplace.comSkip the Oura Ring IPO. Buy These 10 Stocks Instead.investorplace.comJun 5

zacks.comQuest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Knowzacks.comMay 29

zacks.comHere's Why Quest Diagnostics (DGX) is a Strong Value Stockzacks.comMay 28

zacks.comAre Medical Stocks Lagging Quest Diagnostics (DGX) This Year?zacks.comMay 26

Trade DGX

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

CEO: James E. Davis
IPO Date: Dec 17, 1996

Market Data

Market data refresh is queued when this stock page is viewed.

Valuation

Valuation snapshot is not available yet.

Financials

Financial statement snapshot is not available yet.

Events

EarningsJul 28

EPS est. 2.81